NCT03819530

Brief Summary

The first 1,000 days of life are critical periods for brain development. Proper nutrition lays the foundation for optimal growth, health, and neurodevelopment across the lifespan. Poor nutrition in this vulnerable period has irreversible consequences, including stunting, susceptibility to sickness, reduced school performance and productivity, and impaired intellectual and social development. UNICEF reported in 2018 that among the low cost flat residents in urban areas of the Klang Valley, 15% of children under 5 years old were stunted, 22% underweight, and 23% either overweight or obese. Will a micronutrient supplementation program improve the growth and iron status of children aged 6 months to 5 years staying in Lembah Subang? Children will be randomized into treatment and control groups. Treatment groups will receive dietary micronutrient supplementation packets. Measurements of height and weight and iron status will be taken at baseline and 4 months later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 28, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

September 16, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2020

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2020

Completed
Last Updated

August 31, 2022

Status Verified

August 1, 2022

Enrollment Period

6 months

First QC Date

January 15, 2019

Last Update Submit

August 28, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in serum ferritin level between baseline and after 4 months mineral supplementation

    Blood test for serum ferritin level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).

    First blood test upon enrollment, at 0 months. Second blood test at 4 months

  • Change in reticulocyte hemoglobin level between baseline and after 4 months mineral supplementation

    Blood test for RET-He level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).

    First blood test upon enrollment, at 0 months. Second blood test at 4 months

  • Change in C-reactive protein level between baseline and after 4 months mineral supplementation

    Blood test for C-reactive protein level will be done at enrollment (0 months) and again at end of study period, after 4 months of supplementation (or no supplementation for control group).

    First blood test upon enrollment, at 0 months. Second blood test at 4 months

Secondary Outcomes (2)

  • Change in height (cm)

    First height measurement upon enrollment at 0 months. Second height measurement at 6 months.

  • Change in weight (kg)

    First weight measurement upon enrollment at 0 months. Second weight measurement at 4 months.

Study Arms (2)

Supplementation Group

EXPERIMENTAL

Receives baseline deworming medication. Intervention: receive daily micronutrient supplementation packets- 4 month supply, to be taken every day. Blood iron and anthropometric measurements taken at 0 and 4 months.

Dietary Supplement: Vitamin and Mineral Powder

Control Group

NO INTERVENTION

Receives baseline deworming medication. Blood iron and anthropometric measurements taken at 0 and 4 months.

Interventions

Vitamin and Mineral PowderDIETARY_SUPPLEMENT

Vitamin and mineral nutritional supplement. Each packet is 1g of powder, to be taken with food.

Also known as: Multiple Micronutrient Powder
Supplementation Group

Eligibility Criteria

Age6 Months - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 6 months to 5 years living in PPR Lembah Subang

You may not qualify if:

  • Ex-premature babies and children with congenital abnormalities resulting in gross impairment
  • Children whose caregiver did not consent to participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Malaya Medical Center

Kuala Lumpur, Kuala Lumpur, 59100, Malaysia

Location

Related Publications (1)

  • Wang CC, Abdul Jalal MI, Song ZL, Teo YP, Tan CA, Heng KV, Low MSY, Anuar Zaini A, Lum LCS. A Randomized Pilot Trial of Micronutrient Supplementation for Under-5 Children in an Urban Low-Cost Flat Community in Malaysia: A Framework for Community-Based Research Integration. Int J Environ Res Public Health. 2022 Oct 25;19(21):13878. doi: 10.3390/ijerph192113878.

MeSH Terms

Conditions

Anemia, Iron-DeficiencyGrowth Disorders

Interventions

Vitamins

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MicronutrientsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesNutrientsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Lucy Chai See Lum, MD

    University Malaya, Faculty of Medic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Treatment group: receives baseline deworming medication and daily micronutrient supplementation for 4 months; Control group: receives baseline deworming medication only
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2019

First Posted

January 28, 2019

Study Start

September 16, 2019

Primary Completion

February 29, 2020

Study Completion

March 15, 2020

Last Updated

August 31, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Not planning to share patient data.

Locations